Quidel gets another FDA 501(k) nod for flu, RSV/ hMPV assays


The FDA grants 501(k) clearance for Quidel's (QDEL) Molecular Influenza A+B assay and Molecular RSV + hMPV assay for use on Life Technologies' (LIFE) QuantStudio" Dx Real-Time PCR Instrument.

Notable: The Molecular Influenza A+B assay can detect the H7N9 subtype. (PR)

These assays are also cleared for use with Cepheid's (CPHD) SmartCycler II.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs